CRP-32608-21446
2 vaccinations
3 coded responses
25 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 787 / TX
- Registered
- 2021-03-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-23
Registered in v-safe
-
2021-03-23
Dose 1 — Pfizer-BioNTech
-
2021-03-23
Survey response — day 0, dose 1MedDRA: Injection site pain — Feeling: Good · Site: PainFree text: No. And the pain at the injection site is soreness. It started about 2 hours in.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-24
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pain — Feeling: Good · Site: PainFree text: The pain reported at the injection site is simply continued soreness from the shot. It mostly subsided over night, with just a residual bit of soreness remaining.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-04-06
-
2021-04-13
Dose 2 — Pfizer-BioNTech
- 2021-04-13
-
2021-04-14
Survey response — days 1–6 daily, dose 2MedDRA: Injection site pain — Feeling: Good · Site: PainFree text: Pain at injection site similar to first dose: nominal through first day, quite sore by night, nominal soreness the second day. Today (second day), only nominal soreness. All else great!!MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-15
- 2021-04-16
- 2021-04-17
- 2021-04-18
- 2021-04-19
- 2021-04-20
- 2021-04-27
- 2021-05-04
- 2021-05-11
- 2021-05-18
- 2021-05-25
- 2021-07-13
- 2021-10-12
- 2022-04-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-23 | Pfizer-BioNTech | |
| 2 | 2021-04-13 | Pfizer-BioNTech |
Free text
Release 6 — day 0, dose 1
Systemic reaction (other): No. And the pain at the injection site is soreness. It started about 2 hours in.
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): The pain reported at the injection site is simply continued soreness from the shot. It mostly subsided over night, with just a residual bit of soreness remaining.
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Pain at injection site similar to first dose: nominal through first day, quite sore by night, nominal soreness the second day. Today (second day), only nominal soreness. All else great!!
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Injection site pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release